Annual Results 2025-26 | Live Webcast | June 16, 2026 | 6:00pm–7:00 pm CEST | Access live & replay

Events Investors

Videoconference • Collaboration with AbbVie (French)

By MedincellApril 17, 2024July 15th, 2025No Comments

Previous PostMedincell enters into strategic co-development and licensing agreement with AbbVie to develop next-generation long-acting injectable therapies
Next Post[Replay] Videoconference • Collaboration with AbbVie (French)